Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.71 |
| ▸ | MAOB | P27338 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 7/20 | 0.60 |
| ▸ | MEN1 | O00255 | 5/20 | 0.60 |
| ▸ | TP53 | P04637 | 2/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.60 |
| ▸ | LMNA | P02545 | 4/20 | 0.60 |
| ▸ | NR2E1 | Q9Y466 | 1/20 | 0.60 |
| ▸ | USP2 | O75604 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 4/20 | 0.56 |
| ▸ | HTT | P42858 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | NPC1 | O15118 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31350666 | 0.85 | CYP2D6 (0.80) | MAOBKMT2ANPSR1MEN1TP53 | |
| SCHEMBL7943306 | 0.84 | L3MBTL1 (1.00) | L3MBTL1SMN1; SMN2ALDH1A1LMNAHTT | |
| SCHEMBL18705011 | 0.82 | L3MBTL1 (0.76) | L3MBTL1SMN1; SMN2ALDH1A1HTTGAA | |
| SCHEMBL29479773 | 0.82 | L3MBTL1 (0.51) | L3MBTL1MAOBKMT2ANPSR1MEN1 | |
| SCHEMBL24496399 | 0.82 | NPSR1 (0.57) | L3MBTL1MAOBKMT2ANPSR1MEN1 | |
| SCHEMBL1461593 | 0.82 | L3MBTL1 (0.86) | L3MBTL1KMT2ASMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL31350684 | 0.81 | CYP3A4 (0.73) | MAOBKMT2ANPSR1MEN1TP53 | |
| SCHEMBL7955601 | 0.80 | L3MBTL1 (0.89) | L3MBTL1SMN1; SMN2ALDH1A1LMNAHTT | |
| SCHEMBL31350856 | 0.79 | MAOB (0.82) | MAOBKMT2ANPSR1MEN1SMN1; SMN2 | |
| SCHEMBL31351144 | 0.79 | NPSR1 (0.69) | L3MBTL1MAOBKMT2ANPSR1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250084091-A1 | INHIBITORS OF SARS-COV-2 | TEXAS A & M UNIV SYS (US) | 2025-03-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250084091-A1 | INHIBITORS OF SARS-COV-2 | ACE2, ACE, TMPRSS2 | L3MBTL1 3747/4885MAOB 1253/4885KMT2A 2278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.